$3.870
-0.079 (-2.03%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Apimeds Pharmaceuticals US Inc (APUS) Moving Averages Convergence Divergence (MACD) indicator is -0.82, suggesting APUS is Strong sell.
Apimeds Pharmaceuticals US Inc (APUS) 20-Day simple moving average is 4.51, while Apimeds Pharmaceuticals US Inc (APUS) share price is $—, making it Sell.
Apimeds Pharmaceuticals US Inc (APUS) 60-Day simple moving average is 7.43, while Apimeds Pharmaceuticals US Inc (APUS) share price is $—, making it Sell.
Technical Analysis for APUS
AI Technical APUSAs of 2026-08-29, the technical board for Apimeds Pharmaceuticals US Inc (APUS) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $3.87 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 34.284, MACD stands at -0.82 (Sell), Stochastic %K stands at 36.765, Stochastic %D stands at 53.105 and CCI stands at -140.727 (Buy).
APUS trades below the 60-day SMA (7.43) and below the 200-day SMA (110.97). Immediate resistance sits at Classic R1 5.43, then R2 6.45. Support sits at Classic S1 3.39, then S2 2.37.
Apimeds Pharmaceuticals US Inc (APUS) Support & Resistance Level
Apimeds Pharmaceuticals US Inc (APUS) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 34.284 |
| STOCHk_14_3_3 | 36.765 |
| STOCHd_14_3_3 | 53.105 |
| CCI_20 | -140.727 |
| AO_5_34 | -0.905 |
| MOM_10 | -0.680 |
| MACD_12_26_9 | -0.820 |
Apimeds Pharmaceuticals US Inc (APUS) Relative Strength Index (RSI_14) is 34.284, creating a Neutral signal.
Apimeds Pharmaceuticals US Inc (APUS) Stochastic %K is 36.765, creating a Neutral signal.
Apimeds Pharmaceuticals US Inc (APUS) Stochastic %D is 53.105, creating a Neutral signal.
Apimeds Pharmaceuticals US Inc (APUS) CCI_20 is -140.727, creating a Buy signal.
Apimeds Pharmaceuticals US Inc (APUS) Awesome Oscillator (AO) is -0.905, creating a Sell signal.
Apimeds Pharmaceuticals US Inc (APUS) Momentum (MOM) is -0.680, creating a Sell signal.
Apimeds Pharmaceuticals US Inc (APUS) Moving Average Convergence Divergence (MACD) is -0.820, creating a Sell signal.
Apimeds Pharmaceuticals US Inc (APUS) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.428 | Sell |
| MA_10 | 4.404 | Sell |
| MA_20 | 4.515 | Sell |
| MA_60 | 7.430 | Sell |
| MA_200 | 110.972 | Sell |
| MA_250 | 125.447 | Sell |
Apimeds Pharmaceuticals US Inc (APUS) 5-Day simple moving average is 4.428, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
Apimeds Pharmaceuticals US Inc (APUS) 10-Day simple moving average is 4.404, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
Apimeds Pharmaceuticals US Inc (APUS) 20-Day simple moving average is 4.515, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
Apimeds Pharmaceuticals US Inc (APUS) 60-Day simple moving average is 7.430, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
Apimeds Pharmaceuticals US Inc (APUS) 200-Day simple moving average is 110.972, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
Apimeds Pharmaceuticals US Inc (APUS) 250-Day simple moving average is 125.447, while Apimeds Pharmaceuticals US Inc (APUS) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.